EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

KBN2202, a Salicylic Acid Derivative, Preserves Neuronal Architecture, Enhances Neurogenesis, Attenuates Amyloid and Inflammatory Pathology, and Restores Recognition Memory in 5xFAD Mice at an Advanced Stage of AD Pathophysiology

Sun-Young Lee, Jong Chul Kim, Mi Ran Choi, Jiseo Song, Moonhang Kim, Seok-Hwan Chang, Jong Sung Kim, Joon-Suk Park iD, Sang-Rae Lee

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262210942 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Sun-Young Lee und 8 weiteren Autor:innen. Beteiligte Einrichtung: Efficacy Test Center for Mental & Behavioral Disorders (MBD), Ajou University Hospital, Suwon 16499, Republic of Korea. Hauptthemen laut MEDLINE: Neurogenesis, Alzheimer Disease, Neurons, Memory. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea (NRF), funded by the Korean government (MSIT), Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea, Korea Bio-health Technology R&D Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline, amyloid-β (Aβ) pathology, synaptic degeneration, impaired neurogenesis, and chronic neuroinflammation. KBN2202, a small-molecule salicylic acid derivative [2-[(2-naphthalen-1-yloxy)ethyl]amino]-4-hydroxybenzoic acid], was investigated for its potential as a multi-target therapeutic agent in advanced-stage AD. To this end, 9-month-old 5xFAD mice with established AD-like pathology received daily oral KBN2202 (5 or 20 mg/kg) or vehicle for 12 weeks. KBN2202 demonstrated broad histopathological benefits. It preserved hippocampal CA1 cytoarchitecture and increased dendritic length in cortical neurons. Neurogenic activity was also enhanced, with elevated doublecortin (DCX) expression in the subventricular zone (SVZ). At the molecular level, KBN2202 reduced amyloid precursor protein C-terminal fragments (APP-CTFs), key intermediates in amyloidogenic processing, and histological staining confirmed a significant reduction in fibrillar and diffuse Aβ plaque burden in the cortex and hippocampus. Furthermore, KBN2202 attenuated astrocytic and microglial activation, indicating suppression of chronic neuroinflammation. In behavioral assessments, KBN2202 significantly improved recognition memory in the novel object recognition (NOR) test, while Y-maze performance remained unchanged. Overall, the compound exhibited robust neuroprotective, pro-neurogenic, anti-amyloid, and anti-inflammatory effects. These findings support the therapeutic potential of KBN2202 as a multi-functional candidate for symptomatic-stage AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeurogenesisAlzheimer DiseaseNeuronsMemorySalicylic AcidAnimalsDoublecortin ProteinMiceAmyloid beta-PeptidesDisease Models, AnimalMice, TransgenicMaleAmyloid beta-Protein PrecursorInflammationHippocampusNeuroprotective Agents

Stichwörter der Autor:innen

5xFAD miceAlzheimer’s diseaseKBN2202neurogenesisneuroinflammationsalicylic acid derivative

Substanzen

Doublecortin ProteinDcx protein, mouseAmyloid beta-PeptidesAmyloid beta-Protein PrecursorNeuroprotective AgentsSalicylic Acid

Autor:innen und Institutionen

  • Efficacy Test Center for Mental & Behavioral Disorders (MBD), Ajou University Hospital, Suwon 16499, Republic of Korea.
  • Preclinical Research Center, Daegu-Gyeongbuk Medical Innovation Foundation (K-MEDI hub), Daegu 41061, Republic of Korea.
  • Laboratory Animal Research Center, Ajou University School of Medicine, Suwon 16499, Republic of Korea.
  • Department of Pharmacology, Ajou University School of Medicine, Suwon 16499, Republic of Korea.
  • BK21 R&E Initiative for Advanced Precision Medicine, Suwon 16499, Republic of Korea.
  • Department of Biomedical Sciences, Graduate School of Ajou University, Suwon 16499, Republic of Korea.

ORCID-Profile: Joon-Suk Park

Förderung

  • National Research Foundation of Korea (NRF), funded by the Korean government (MSIT)
  • Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea
  • Korea Bio-health Technology R&D Project
  • Korea Health Technology R&D Project
  • Ministry of Health & Welfare, Republic of Korea
  • Bio&Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government

Zitieren

APA

Lee, S. Y., Kim, J. C., Choi, M. R., Song, J., Kim, M., Chang, S. H., Kim, J. S., Park, J. S., & Lee, S. R. (2025). KBN2202, a Salicylic Acid Derivative, Preserves Neuronal Architecture, Enhances Neurogenesis, Attenuates Amyloid and Inflammatory Pathology, and Restores Recognition Memory in 5xFAD Mice at an Advanced Stage of AD Pathophysiology. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262210942

Vancouver

Lee SY, Kim JC, Choi MR, Song J, Kim M, Chang SH, et al. KBN2202, a Salicylic Acid Derivative, Preserves Neuronal Architecture, Enhances Neurogenesis, Attenuates Amyloid and Inflammatory Pathology, and Restores Recognition Memory in 5xFAD Mice at an Advanced Stage of AD Pathophysiology. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262210942

BibTeX
@article{Lee2025,
  author = {Lee, Sun-Young and Kim, Jong Chul and Choi, Mi Ran and Song, Jiseo and Kim, Moonhang and Chang, Seok-Hwan and Kim, Jong Sung and Park, Joon-Suk and Lee, Sang-Rae},
  title = {KBN2202, a Salicylic Acid Derivative, Preserves Neuronal Architecture, Enhances Neurogenesis, Attenuates Amyloid and Inflammatory Pathology, and Restores Recognition Memory in 5xFAD Mice at an Advanced Stage of AD Pathophysiology},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262210942}
}
Kostenlos starten →